Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. Author Gregory Ducker, Li Chen, Raphael Morscher, Jonathan Ghergurovich, Mark Esposito, Xin Teng, Yibin Kang, Joshua Rabinowitz Publication Year 2016 Type Journal Article Abstract One-carbon (1C) units for purine and thymidine synthesis can be generated from serine by cytosolic or mitochondrial folate metabolism. The mitochondrial 1C pathway is consistently overexpressed in cancer. Here, we show that most but not all proliferating mammalian cell lines use the mitochondrial pathway as the default for making 1C units. Clustered regularly interspaced short palindromic repeats (CRISPR)-mediated mitochondrial pathway knockout activates cytosolic 1C-unit production. This reversal in cytosolic flux is triggered by depletion of a single metabolite, 10-formyl-tetrahydrofolate (10-formyl-THF), and enables rapid cell growth in nutrient-replete conditions. Loss of the mitochondrial pathway, however, renders cells dependent on extracellular serine to make 1C units and on extracellular glycine to make glutathione. HCT-116 colon cancer xenografts lacking mitochondrial 1C pathway activity generate the 1C units required for growth by cytosolic serine catabolism. Loss of both pathways precludes xenograft formation. Thus, either mitochondrial or cytosolic 1C metabolism can support tumorigenesis, with the mitochondrial pathway required in nutrient-poor conditions. Keywords Humans, Cell Proliferation, Mutation, Gene Library, HEK293 Cells, Colonic Neoplasms, Cytosol, Mitochondria, Cell Compartmentation, Metabolic Networks and Pathways, Ribonucleotides, Carbon, Folic Acid, NADP, CRISPR-Cas Systems, Serine, Formates, HCT116 Cells, Aminoimidazole Carboxamide, Gene Knockout Techniques, Glycine, Glycine Hydroxymethyltransferase, Leucovorin, Methylenetetrahydrofolate Dehydrogenase (NADP), Xenograft Model Antitumor Assays Journal Cell Metab Volume 23 Issue 6 Pages 1140-1153 Date Published 2016 Jun 14 ISSN Number 1932-7420 DOI 10.1016/j.cmet.2016.04.016 Alternate Journal Cell Metab PMCID PMC4909566 PMID 27211901 PubMedPubMed CentralGoogle ScholarBibTeXEndNote X3 XML